Children

Correspondence from The New England Journal of Medicine — Household Transmission of SARS-CoV-2 from Children and Adolescents // 2.11.2021

Background Long-term health sequelae of the coronavirus disease 2019 (COVID-19) are a major public health concern. However, evidence on post-acute COVID-19 syndrome (post COVID-19) is still limited, particularly for children and adolescents. / 22.10.2021

Lastenlääkärin mukaan korona aiheuttaa lapsissa hyvin samanlaisia oireita kuin muutkin infektiotaudit. Sairaalahoidon syynä usein korkea kuume. Lapsia on koronan takia ollut sairaalahoidossa jopa yllättävän vähän. // 5.11.2021

A new preprint describes an effort to describe the risk factors for severe COVID-19 in children. // 2.11.2021

The current study compares the severity of the illness in children infected by the wild-type strain compared with the VOC now prevalent in terms of outcomes in this age group. // 1.11.2021

New research addresses the misconception that children are less susceptible to infection with the new coronavirus. / 30.10.2021

A new study presents data on long covid in adults and children, which is becoming a major issue in public health planning. // 26.10.2021

The latest round of the REACT-1 study indicates SARS-CoV-2 continues to spread among children. // 26.10.2021

A new study posted to the medRxiv* preprint server explores environmental surveillance of elementary school settings for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through wastewater and surface samples monitoring. The researchers demonstrated that 93% of the COVID-19 cases in public elementary schools could be identified using this method. // 26.10.2021

This paper examines whether the opening of K–12 schools may lead to the spread of COVID-19. Analyzing how an increase of COVID-19 cases is related to the timing of opening K–12 schools in the United States, we find that counties that opened K–12 schools with in-person learning experienced an increase in the growth rate of cases by 5 percentage points on average, controlling for a variety of policies, past infection rates, and other factors. // 19.10.2021

News-Medical speaks to Dr. Usha Sethuraman about her research into COVID-19 and how saliva could be used to help predict COVID-19 severity in children. // 22.10.2021

This report describes Pfizer-BioNTech vaccine effectiveness against COVID-19 hospitalization.

Tutkimuksen perusteella lasten rooli taudin levittäjinä voi olla oletettua suurempi. // 16.10.2021

Weekly COVID-19 hospitalization rates among US children and adolescents increased 5-fold this past summer as the B.1.617.2 (Delta) variant became the dominant circulating strain, according to data from the Coronavirus Disease 2019–Associated Hospitalization Surveillance Network (COVID-NET). // 12.10.2021

A new study confirms that children can carry high viral loads of SARS-Co-V-2, making them possible spreaders of current and emerging variants. // 14.10.2021

Data on pediatric COVID-19 has lagged behind adults throughout the pandemic. An understanding of SARS-CoV-2 viral dynamics in children would enable data-driven public health guidance. // 14.10.2021 Viral loads in children with asymptomatic or mild infections were higher than in children or adults with severe disease. Viral load and replication-competent virus in children was highest in the first 2 days of symptoms and decreased after 5 days

A new study finds that counties that opened K–12 schools experienced a significant increase in the growth rate of cases. // 14.10.2021

A recent preprint discusses the antibody response to the nucleic acid vaccines against SARS-CoV-2 when administered to children aged 7-11 years. // 12.10.2021

Researchers have investigated the differences between 'classic' myocarditis, COVID-19 induced myocarditis, and vaccine-related myocarditis. // 11.10.2021

This cohort study uses data from a primary school in Belgium to examine the possible role of children in the transmission of SARS-CoV-2. // 12.10.2021

Teen's death believed to be the first recorded fatality in Israel from PIMS, a rare condition that develops in some children after contracting coronavirus // 9.10.2021

// 10.10.2021

During the early phases of the SARS-CoV-2 pandemic, children were sheltered and protected from exposures and infection with this new respiratory virus. They were also thought to be less susceptible and were not tested or diagnosed as often as adults. // 8.10.2021

// 7.10.2021

Background and Objectives Case-based surveillance of pediatric COVID-19 cases underestimates the prevalence of SARS-CoV-2 infections among children and adolescents. / 29.9.2021

This cohort study of households in selected Utah counties and New York City, New York, compares incidence rates and clinical characteristics of SARS-CoV-2 infection among adults and children and prospectively assesses infection risks. // 8.102021

Multisystem inflammatory syndrome in children (MIS-C) is a serious condition associated with a recent COVID-19 infection. // 7.10.2021

This study investigated the dynamics of SARS-CoV-2 infection and diagnostics in household members of different ages and with different symptom severity after SARS-CoV-2 exposure during the early phase of the pandemic. “…children displayed higher viral loads at the day of symptom onset compared to adults, while the decay in viral load was comparable.(…)if children become infected with SARS-CoV-2, they can carry high loads of virus for a longer time compared to adults.” // 6.10.2021

The lingering symptoms of Multisystem Inflammatory Syndrome in Children, or MIS-C, require a team approach for treatment. Children who are recovering from MIS-C, which appears after even mild cases of COVID-19, are being treated at a multidisciplinary outpatient specialty clinic inside the Kathy and Joe Sanderson Tower at Children’s of Mississippi. // 4.10.2021

Nature Immunology - Pediatric COVID-19 can be associated with subsequent multisystem inflammatory syndrome in children (MIS-C), but how these pathologies are related or differ is unclear. // 5.10.2021